Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T (2025) JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure. Circ J 89(8):1278–1444
Kitao T, Hikoso S, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Sotomi Y, Nakatani D, Yamada T, Yasumura Y, Sakata Y, Investigators OC-HF (2025) Post-discharge changes in nutritional status predict prognosis in patients with acute decompensated HFpEF from the PURSUIT-HFpEF Registry. Heart Vessels 40:577–591
Nishino M, Egami Y, Sugino A, Kobayashi N, Abe M, Ohsuga M, Nohara H, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Okamoto N, Matsunaga-Lee Y, Yano M, Yamada M, Yasumura Y, Seo M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Okada K, Sotomi Y, Nakatani D, Hikoso S, Sakata Y, Osaka CardioVascular Conference -Heart Failure I (2025) Characteristics of comparatively young heart failure with preserved ejection fraction: PurSuit-HFpEF registry. Heart Vessels 40:863–873
Gazewood JD, Turner PL (2017) Heart Failure with Preserved Ejection Fraction: Diagnosis and Management. Am Fam Physician 96:582–588
Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P (2005) Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352:1951–1958
Article CAS PubMed Google Scholar
Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886–894
Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875–885
Article CAS PubMed Google Scholar
Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR (2017) The Clinical Use of Ivabradine. J Am Coll Cardiol 70:1777–1784
Bohm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, McKelvie RS, Anand IS, Massie BM, Carson PE, McMurray JJ, Committees IP, Investigators (2014) Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). Eur J Heart Fail 16:778–787
Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Bohm M, prEserve DFI (2017) Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Eur J Heart Fail 19:1495–1503
Article CAS PubMed Google Scholar
Conceicao LSR, Gois C, Fernandes RES, Souza DS, Junior MBG, Carvalho VO (2021) Effect of ivabradine on exercise capacity in individuals with heart failure with preserved ejection fraction. Heart Fail Rev 26:157–163
Article CAS PubMed Google Scholar
Fujimoto W, Toh R, Takegami M, Imanishi J, Hamana T, Odajima S, Takemoto M, Kuroda K, Hatani Y, Yamashita S, Iwasaki M, Inoue T, Okamoto H, Todoroki T, Okuda M, Hayashi T, Konishi A, Tanaka H, Shinohara M, Nagao M, Murata S, Ogata S, Nishimura K, Hirata KI (2023) Aetiology of chronic heart failure in patients from a super-aged society: the KUNIUMI registry chronic cohort. ESC Heart Fail 10:100–110
Odajima S, Fujimoto W, Takegami M, Nishimura K, Iwasaki M, Okuda M, Konishi A, Shinohara M, Nagao M, Toh R, Hirata KI, Tanaka H (2024) BEEAF(2) Score: A New Risk Stratification Score for Patients With Stage B Heart Failure From the KUNIUMI Registry Chronic Cohort. J Am Heart Assoc 13:e034793
Article PubMed PubMed Central Google Scholar
Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H, Investigators C- (2011) Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan–first report from the CHART-2 study. Circ J 75:823–833
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39 e14
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30:303–371
Yamamoto K, Origasa H, Hori M, Investigators JD (2013) Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail 15:110–118
Article CAS PubMed Google Scholar
Tanaka H, Yamauchi Y, Imanishi J, Hatani Y, Odajima S, Okamoto H, Hayashi T, Hirata KI (2022) Effect of Ivabradine on Left Ventricular Diastolic Function of Patients With Preserved Ejection Fraction - Results of the IVA-PEF Study. Circ Rep 4:499–504
Article PubMed PubMed Central Google Scholar
Noiri J, Fujimoto W, Takemoto M, Kuroda K, Yamashita S, Imanishi J, Iwasaki M, Todoroki T, Okuda M, Nagao M, Konishi A, Shinohara M, Toh R, Nishimura K, Tanaka H (2025) Population Gap for Chronic Heart Failure Patients Between Randomized Controlled Trials and Japan’s Super-Aged Society. Circ Rep 7:331–340
Comments (0)